Domestic pharmaceutical industry calls for overhaul of new drug pricing policy

Many pharmaceutical firms is strongly opposing the projected drug price re-evaluation system that the government intends to introduce from this September 1, saying that the new system will lead to a tremendous damage to the pharmaceutical industry following a series of price reduction of drugs in the process of the plan, although the government purport is somewhat understandable for better fina...